Abstract:Purpose Esophageal cancer is the most common gastrointestinal tumor and is difficult to be eradicated with conventional treatment. Porphyrin-based photosensitizers (PSs) mediated photodynamic therapy (PDT) could kill tumor cells with less damage to normal cells. As the most widely used porphyrin-based photosensitizer in clinics, Photofrin II has excellent anti-tumor effect. However, it has some disadvantages such as weak absorption at near infrared region, the complexity of components and prolonged skin photosensitivity. Here series novel 5,15-diaryl-10,20-dihalogeno porphyrin derivatives were afforded and evaluated to develop more effective and safer photosensitizers for tumor therapy. Methods The photophysical properties and singlet oxygen generation rates of 5,15-diaryl-10,20-dihalogeno porphyrins ( I 1-6 , II 1-4 ) were tested. The cytotoxicity of I 1-6 and II 1-4 were measured by MTT assay. The pathway of cell death was studied by flow cytometry. In vivo photodynamic efficacy of I 3 and II 2-4 in Eca-109 tumor-bearing BABL/c nude mice were measured and histopathological analysis were examined. Results 5,15-Diaryl-10,20-dihalogeno porphyrins I 1-6 and II 1-4 were synthesized. The longest absorption wavelength of these halogenated porphyrins ( λ max = 660 nm) displayed a red shift around 30 nm compared to the unhalogenated porphyrins PS 1 ( λ max = 630 nm). The singlet oxygen generation rates of I 1-6 and II 1-4 were significantly higher than PS 1 and HMME. All PSs mediated PDT showed obvious cytotoxic effect against Eca-109 cells compared to HMME in vitro and in vivo. Among these PSs, II 4 exhibited appropriate absorption in the phototherapeutic window, higher 1 O 2 generation rate ( k = 0.0061 s −1 ), the strongest phototoxicity (IC 50 = 0.4 μM), lower dark toxicity, high generation of intracellular ROS in Eca-109 cells and excellent photodynamic anti-tumor efficacy in vivo. Besides, cell necrosis was induced by compound II 4 mediated PDT. Conclusion All new compounds have obvious photodynamic anti-esophageal cancer effects. Among them, the photosensitizer II 4 showed excellent efficacy in vitro and in vivo, which has the potential to become a photodynamic anti-tumor drug.

Metalloporphyrin–indomethacin conjugates as new photosensitizers for photodynamic therapy

Platinated Porphyrin As A New Organelle and Nucleus Dual-Targeted Photosensitizer for Photodynamic Therapy

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

N-Methylpyridylporphyrin Tailed with Folate Conjugate As a Potential Lysosomal-Targeted Photosensitizer: Synthesis, DNA Interaction, Singlet Oxygen and Subcellular Localization

Platinated Porphyrin Tailed with Folic Acid Conjugate for Cell-Targeted Photodynamic Activity

Porphyrin photosensitizer molecules as effective medicine candidates for photodynamic therapy: electronic structure information aided design

Synthesis and antitumor study of novel porphyrin–coumarin derivatives for chemotherapy and photodynamic therapy

Zinc phthalocyanine-bridged periodic mesoporous organosilica nanoparticle as biodegradable photosensitizer for photodynamic therapy

Biocompatible conjugated porphyrin nanoparticles with photodynamic/photothermal performances in cancer therapy

Synthesis and evaluation of novel mitochondria-targeted, water-soluble phenoxazine-porphyrins for efficient photodynamic therapy

Metal-conjugated Maltotriose Chlorins as Novel Photosensitizers for Photodynamic Therapy

Mitochondria-targeting Pt/Mn Porphyrins As Efficient Photosensitizers for Magnetic Resonance Imaging and Photodynamic Therapy

Highly effective self-assembled porphyrin MOCs nanomaterials for enhanced photodynamic therapy in tumor

Modulating the phototoxicity and selectivity of a porphyrazine towards epidermal tumor cells by coordination with metal ions

Design, synthesis, and evaluation of 5,15-diaryltetranaphtho [2,3]porphyrins as photosensitizers in real-time photodynamic therapy and photodiagnosis

The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy

Synthesis and Antitumor Activity of Photosensitizer Eugenol Porphyrin Derivatives: A Combination Therapy of Chemotherapy and Photodynamic Therapy

Pt/Pd dual-modified porphyrin metal-organic frameworks for NIR-II photothermal-enhanced photodynamic/catalytic therapy

Synthesis of Three Cisplatin-Conjugated Asymmetric Porphyrin Photosensitizers for Photodynamic Therapy.

Recent advances of multi-dimensional porphyrin-based functional materials in photodynamic therapy

pH-responsive Photinia glabra-zinc oxide-protoporphyrin IX nanoconjugates with enhanced cellular uptake for photodynamic therapy towards cancer cells